Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC).

Harrold, E; Solter, M; Walch, HS; Chatila, WK; Keane, F; Lumish, MA; Yaeger, R; Weiss, JA; Palmaira, RL; Krishnan, A; Diaz, LA; Stadler, ZK; Cercek, A

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):